Cytomegalovirus (CMV) Infection Treatment and Diagnosis Market

Cytomegalovirus (CMV) Infection Treatment and
Diagnosis Market - Size, Share, Growth,
Outlook, and Opportunity Analysis, 2018-2026
Cytomegalovirus (CMV) is a virus that belongs to herpes virus family that remain dormant in the
human body. CMV infection can occur in people of all ages worldwide. CMV is a communicable
disease that spreads through body fluids such as saliva, blood, urine, semen, and breast milk.
Presence of CMV infection can be detected by various testing methods based on which the global
cytomegalovirus infection treatment and diagnosis market can be analyzed:
• Serologic test
• Polymerase chain reaction (PCR) test
Request Sample Copy of Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/167
Cytomegalovirus infection market: Treatment approach
People diagnosed with high risk of CMV infection may be given anti-viral medications to prevent
the disease to get in to active stage. There is no cure available for treating the CMV infection.
Ganciclovir, Val ganciclovir, Cidofovir, Valacyclovir and Foscarnet are few major anti-viral
medications prescribed. In some cases, CMV immune globulin contains antibodies (proteins) may
be prescribed to prevent CMV infection. There are certain products in pipeline which includes
Cytovir CMV, Letermovir, CytoTect CP 70, Brincidofovir and ASP0113, commercialization of which
is expected to fuel the global CMV infection treatment and diagnosis market growth in the near
future.
Vital statistics for the global cytomegalovirus infection treatment and diagnosis
market
Besides, diagnosis of new CMV cases would be a propelling factor for global cytomegalovirus
infection treatment and diagnosis market. The Public Health Agency of Canada estimates that
40%-100% of the global population have CMV antibody present in their body.
Immunocompromised patients (HIV, organ transplant), premature infants, newborns and with
congenital CMV are at high risk of developing serious illness with CMV infection.
Report includes chapters which deeply display the following deliverable about industry :
• Cytomegalovirus (CMV) Infection Treatment and Diagnosis Market Research Objective and
Assumption
• Cytomegalovirus (CMV) Infection Treatment and Diagnosis Market Purview - Report Description,
Executive Summary, and Coherent Opportunity Map (COM)
• Cytomegalovirus (CMV) Infection Treatment and Diagnosis Market Dynamics, Regulations, and
Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions,
New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Cytomegalovirus (CMV) Infection Treatment and Diagnosis Market, By Regions
• Cytomegalovirus (CMV) Infection Treatment and Diagnosis Market Competition by Manufacturers
including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area
and Product Type.
• Cytomegalovirus (CMV) Infection Treatment and Diagnosis Market Manufacturers Profiles/Analysis
including Company Basic Information, Manufacturing Base and Its Competitors.
• Cytomegalovirus (CMV) Infection Treatment and Diagnosis Market Manufacturing Cost Analysis
including Key Raw Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning
and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Cytomegalovirus (CMV) Infection Treatment and Diagnosis Market Forecast including Production,
Consumption, Import and Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Some of the major players in the global cytomegalovirus infection treatment and
diagnosis market are Merck & Co. Inc., Cell Medical Ltd., Chimerix, Inc., Affymetrix,
Inc., Abbott Laboratories, Inc., Becton, Dickinson and Company, Johnson & Johnson,
Bio-Rad Laboratories, Inc., and F. Hoffmann-La Roche Ltd.
Inquire Here Before Purchase:
https://www.coherentmarketinsights.com/insight/talk-to-analyst/167
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]